Search
Search Results
Found 17 items.
-
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231078PDF: 375 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024184PDF: 94 -
Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention
Published: 23 June 2023893PDF: 149 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241175PDF: 164 -
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
Published: 22 April 2024184PDF: 30 -
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
Published: 9 March 2023448PDF: 294 -
-
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
Published: 14 December 2022573PDF: 246 -
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review
Published: 24 October 2022375PDF: 139 -
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Published: 27 June 2023900PDF: 199Supplementary File: 90 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024358PDF: 106 -
New perspectives for prevention of the post-thrombotic syndrome
Published: 22 March 20221181PDF: 383 -
-
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
Published: 27 January 2023485PDF: 235 -
Polycythemia vera and management of the thrombotic risk: an update
Published: 20 December 20231613PDF: 182
1 - 17 of 17 items